黃超蘭，教授、博士生導(dǎo)師。曾獲北京市HiCOOL國(guó)際大獎(jiǎng)賽二等獎(jiǎng)（醫(yī)藥組第一名），國(guó)際HUPO“臨床轉(zhuǎn)化蛋白質(zhì)組學(xué)科學(xué)獎(jiǎng)”，北京市“海英人才獎(jiǎng)”。獲得國(guó)家自然科學(xué)原創(chuàng)基金、科技部重點(diǎn)研發(fā)等多個(gè)項(xiàng)目資助。
      院校引進(jìn)人才，2022年加入院校。曾于2005年在美國(guó)斯克里普斯研究所從事博士后研究，隨后獲聘為研究所長(zhǎng)聘資深職位科學(xué)家。2013年-2017年，任中科院國(guó)家蛋白質(zhì)科學(xué)中心質(zhì)譜系統(tǒng)主任，中心主任助理。2017年-2022年任北京大學(xué)醫(yī)學(xué)部精準(zhǔn)醫(yī)療多組學(xué)研究中心創(chuàng)始主任。

長(zhǎng)期致力于質(zhì)譜新技術(shù)研發(fā)及蛋白質(zhì)組學(xué)方法應(yīng)用，自主開(kāi)發(fā)了集“臨床蛋白質(zhì)組學(xué)、AI驅(qū)動(dòng)的多組學(xué)數(shù)據(jù)建模、生物標(biāo)志物發(fā)現(xiàn)、新藥靶點(diǎn)篩選”于一體的閉環(huán)創(chuàng)新藥物靶點(diǎn)發(fā)現(xiàn)體系。目前已有多條研發(fā)管線已進(jìn)入臨床轉(zhuǎn)化階段，并獲得多項(xiàng)專利授權(quán)。在國(guó)際頂尖期刊上發(fā)表論文100余篇，總引超過(guò)8000次，H-index為49。2014年入選中科院“引進(jìn)杰出技術(shù)人才計(jì)劃”，2020年負(fù)責(zé)的研究項(xiàng)目入選“中國(guó)生命科學(xué)十大進(jìn)展”和中國(guó)醫(yī)學(xué)科學(xué)院“重要醫(yī)學(xué)進(jìn)展”。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Li XM#, Gu YN#, Teng T#, Lei TT, He TQ, Wang SY*, Zhou XY*, Wong CCL*. The unique plasma proteome signatures distinguish adolescent mental disorders of major depressive disorder, bipolar disorder and schizophrenia. Sci Bull (Beijing). 2025 Aug;S2095-9273(25)00810-2. (IF=21.1)

2. Gu X#, Wang S#, Zhang W#, Li C#, Guo L#, Wang Z, Li H, Zhang H, Zhou Y, Liang W, Li H, Liu Y, Wang Y, Huang L, Dong T, Zhang D*, Wong CCL*, Cao B*. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine. 2023 Dec;98:104851. (IF=11.1)

3. He C#, Wong CCL*. Novel Proteoform Discovery by Precise Semi-De Novo Sequencing of Novel Junction Peptides. Analytical Chemistry. 2023 Jul;95(28):10610-10617. (IF=7.4)

4. Xin H#, Huang R#, Zhou M#, Chen J#, Zhang J, Zhou T, Ji S, Liu X, Tian H, Lam SM, Bao X, Li L, Tong S, Deng F, Shui G, Zhang Z*, Wong CCL*, Li M*. Day Time-restricted Feeding Enhances Running Endurance Without Prior Exercise in Mice. Nature Metabolism. 2023 Jul;5(7):1236-1251. (IF=20.8)

5. Dang Y#, Zhu L#, Yuan P#, Liu Q#, Guo Q, Chen X, Gao S, Liu X, Ji S, Yuan Y, Lian Y, Li R, Yan L*, Wong CCL*, Qiao J*, Functional profiling of stage-specific proteome and translational transition across human pre-implantation embryo development at a single-cell resolution. Cell Discovery. 2023 Jan;9(1):10. (IF=33.5)

6. Tian W^#, Li D^#, Zhang N^#, Bai G^#, Yuan K, Xiao H, Gao F*, Chen Y*, Wong CCL*, Gao GF*. O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule. Cell Res. 2021 Oct;31(10):1123-1125. (IF=25.6)

7. Su R#, Fan L#, Cao C#, Wang L, Du Z, Cai Z, Ouyang Y, Wang Y, Zhou Q, Wu L, Zhang N, Zhu X, Lei W, Zhao H, Tian Y, He S, Wong CCL*, Sun Q*, Xue Y*. Global Profiling of RNA-Binding Protein Target Sites in Single Cells by LACE-seq. Nature Cell Biology. 2021 Jun;23(6):664-675. (IF=28.8)

8. Tian W^#, Zhang N^#, Jin R^#, Feng Y^#, Wang S^#, Gao S, Gao R, Wu G, Tian D, Tan W*, Chen Y*, Gao GF*, Wong CCL*. Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020 Nov 17;11(1):5859. (IF=12.1, C100)

9. Wu W^#, Zhou Q^#, Masubuchi T^#, Shi X^#, Li H, Xu X, Huang M, Meng L, He X, Zhu H, Gao S, Zhang N, Jing R, Sun J, Wang H, Hui E*, Wong CCL*, Xu C*. Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy. Cell. 2020 Aug 20;182(4):855-871.e23. (IF=38.6, C100)

10. Li ZY^#, Huang M, Wang XK, Zhu Y, Li JS, Wong CCL*, Fang Q*. Nanoliter-Scale Oil-Air-Droplet Chip-Based Single Cell Proteomic Analysis. Anal Chem. 2018 Apr 17;90(8):5430-5438.(IF=6.0, C100)